Posts

Showing posts with the label Genomics Market Share

Genomics - Latest Research and News

Image
What is Genomics – Genomics is that part of biology which deals with all the operations on genomes, such as finding out information about its structure, function and evolution, along with mapping and editing it. So basically, it aims at the collective characterization and quantification of all of an organism’s genes, their interrelations and influence on the organism. Before diving deep into the sea of know-hows of genomics, lets just have a brief swim in the market value of the genomics.  Genomics market   is one of those upbeat markets that grows year-on-year with one of the highest growth rates. According to a market research company, Grand View Research, Inc., this market was valued at USD 20.1 billion in 2020 and is expected to grow at CAGR of 15.35% from 2021 to 2028. These numbers speak volumes about the potential this market holds. Now the question arises, why it holds such a potential and what is it exactly? Genomics – What & Why? To understand genomics as a subject, we ne

Genomics Market Exhibiting At A CAGR Of 15.35%From 2021 To 2028

  San Francisco, 23 March 2021:   The Report  Genomics Market  Size, Share & Trends Analysis Report By Application & Technology (Functional Genomics, Pathway Analysis), By Deliverable (Products, Services), By End-use, By Region, And Segment Forecasts, 2021 - 2028 The global genomics market size is expected to reach USD 62.9 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 15.35% from 2021 to 2028. A rise in the demand for the solutions to catalog vast genomic information into a usable form and to utilize it in clinical workflows is expected to drive the market. This has also led to an increase in the market competition, coupled with the development of breakthrough genomic technologies by Veritas Genetics, 23andMe, and other key players. In August 2020, Ancestry launched a new next-generation sequencing-based tool to screen genes linked to blood disorders, colon cancer, heart diseases, and breast cancer. This product,

Genomics Market Size To Exceed USD 27.61 Billion By 2025 : Grand View Research Inc.

San Francisco, 12 August 2019:   The Report   Genomics Market   Size, Share & Trends Analysis Report By Application And Technology (Pathway Analysis, Functional Genomics), By Deliverables (Instruments, Consumables, Services), By End Use, And Segment Forecasts, 2019 – 2025 The global genomics market size is expected to reach USD 27.61 billion by 2025, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 8.6% during the forecast period. The past decades have witnessed significant changes in disease management processes due to simultaneous advancements in genomics and personalized medicine. There has been a gradual growth in the usage of genomic studies in clinical practices, which is reflected by the growing trend of targeted therapies. Results from genomic studies enable a better understanding of diseases and the underlying mechanisms for researchers, physicians, and consumers. This facilitates evidence-based decision-making, and hence

Genomics Market Expected To Encourage Expansion At A CAGR 9.1% For Forecast Period From 2019 To 2025: Grand View Research Inc.

San Francisco, 29 March 2019:  The Report  Genomics Market  Size, Share & Trends Analysis Report By Deliverables, By Application & Technology (Functional Genomics, Epigenomics), By End Use (Pharma & Biotech Companies), And Segment Forecasts, 2019 – 2025 The global Genomics Market size is expected to reach USD 27.6 billion by 2025, according to a new report by Grand View Research, Inc. The market is projected to expand at a CAGR of 9.1% over the forecast period. The past decades have witnessed significant changes in disease management processes due to simultaneous advancements in genomics and personalized medicine. There has been a gradual growth in the usage of genomic studies in clinical practices, which is reflected by the rising trend of targeted therapies. Results from genomic studies enable a better understanding of diseases and the underlying mechanisms for researchers, physicians, and patients. This facilitates evidence-based decision-making, and hence, hel